Yes, the digital therapeutics market is taking off...
The company provides customers with a platform to empower clinical research while optimizing the experience and outcomes for patients and researchers.
The platform unites providers, payers, operators and entrepreneurs to fuel healthcare innovations.
It has found 2017 to be the record-smashing year for the industry, with the highest amount of venture funding and the most mega deals ($100M+) to date.
The third quarter VC funding came to $1.5B in 227 deals, a 38 percent decrease compared to the record $2.4B raised in 194 deals in Q2 2017.
The Eight Roads China Healthcare Fund has secured $250M to invest in China, while OrbiMed has $551M for investments in China and India.
The telehealth company has reported quarterly revenues of $42.9 million, representing 60% year-over-year growth.
The company reported Q1 revenues of $299 million with U.S. accounting for 52% of the figure.
BlueCross BlueShield Venture Partners invests in higi to expand the ecosystem that will personalize population health.
The company's 2016 revenues have hit $123.2 million for a growth of 59%; almost a third of all visits were in the fourth quarter.